Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study

• Eiichiro Yamamoto,
• Keisuke Ohba,
• Yoshihiro Hirata,
• Takanori Tokitsu,
• Koichiro Fujisue,
• Koichi Sugamura,
• Koichi Kaikita,
• Seiji Hokimoto,
• Seigo Sugiyama,
• Hisao Ogawa

Affiliations

Eiichiro Yamamoto

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Keisuke Ohba

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Yoshihiro Hirata

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Takanori Tokitsu

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Koichiro Fujisue

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Koichi Sugamura

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Koichi Kaikita

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Seiji Hokimoto

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Seigo Sugiyama

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Hisao Ogawa

Faculty of Life Sciences, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan